India Pharma ExportTrusted Medicines. Healthier Tomorrow.
Tier 2 (Korea) and Tier 3 (Philippines, Vietnam, Myanmar, Cambodia, Sri Lanka, Nepal)

Pharma Export to South-East Asia from India

A fast-growing, price-competitive corridor where India already has an established generics presence. Most South-East Asian markets outside Korea fall into the emerging/ROW registration tier, making this — alongside Africa — a realistic starting corridor for new exporters, particularly for generics, APIs and AYUSH categories.

Countries: Philippines, Vietnam, Myanmar, Cambodia, Sri Lanka, Nepal, South Korea

What Sells in This Market

Generic formulations across most therapeutic classesAPIsAYUSH and nutraceutical productsAntimalarials (Cambodia, Myanmar — Greater Mekong region)

Regulatory Pathway

Pathway

FDA Philippines, DAV (Vietnam), and equivalent national regulators for Tier 3 countries; a more structured, semi-regulated pathway applies in South Korea.

Plant Requirement

WHO-GMP + COPP is generally accepted across Tier 3 countries in this region.

Timeline

4–18 months per product in Tier 3 countries; longer in South Korea

Barrier to Entry

Low to medium, varies sharply by country

Regulatory Considerations

  • Registration requirements vary sharply from country to country within this region — there is no single 'South-East Asia' dossier
  • AYUSH and nutraceutical products generally face a lighter food-supplement pathway rather than drug registration
  • APIs are a strong fit for this corridor given the region's own formulation manufacturing base

Documentation

  • Commercial invoice
  • Packing list
  • Certificate of Origin
  • Certificate of Analysis
  • Certificate of Pharmaceutical Product (COPP)
  • Free Sale Certificate
  • Import permit of the buyer

Market Opportunity

A realistic and growing corridor for generics, APIs and AYUSH/nutraceutical categories, with fewer regulatory barriers than Tier 1 or Tier 2 markets outside Korea.

Frequently Asked Questions

Philippines, Vietnam, Myanmar, Cambodia, Sri Lanka and Nepal fall into the emerging/ROW registration tier and are generally the most accessible for a new exporter; South Korea is a more structured, semi-regulated market.

Typical Buyer Types

  • Licensed importers and distributors
  • Wholesale pharmacy chains
  • Hospital groups
  • Government and institutional tenders
Requirements vary by product and destination. This page describes the general market landscape, not company-specific sales coverage or a guarantee of registration outcome.
Request a Quote for South-East Asia

Ready to Source for South-East Asia?

Get a Quote